Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-7400917
  • Global Breast Cancer Imaging Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: August 2017 | Report Code: HME-7400917

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Breast imaging is used to detect cancer cells in the breasts of some women who have abnormal mammograms. Some of the breast imaging techniques is diagnostics ultrasound, breast MRI and full-field digital mammography. OBRC Analysis estimates global breast imaging market to grow at a CAGR of 8.5% during the forecasted period of 2016-2023. The key trends for the global breast imaging market are emergence of microwave tomography imaging; 3D ultrasonic holography and technological innovations in breast cancer detection are some factors that are driving the need for breast imaging techniques across the global. Some of prominent drivers of the global breast imaging market are increasing awareness about early detection of breast cancer, rising prevalence of breast cancer, government investments and funding for breast cancer treatment and related research, launch of advanced systems capable of detecting cancer in women with dense breast tissue and rapidly increasing aging population. The key restraining factors for the global breast imaging market are high installation costs of breast imaging systems, side effects of radiation exposure, unfavorable reimbursement scenario in developing countries and errors in breast cancer screening and diagnosis. The major challenge for the global breast cancer market is stringent regulatory approval procedures, to overcome this challenge the market also have opportunities such as technological innovations in breast cancer detection and emerging economies offer high growth potential.

The key driving factors for the global breast imaging market is rising prevalence of breast cancer. Breast cancer is very common nowadays, factors that are responsible for this disease are genes responsible for amending the growth of the cells, mutations and abnormal changes. Rising prevalence of breast cancer generates the demand for the breast cancer imaging techniques and procedures. According to the Breast Cancer Organization, in 2017, every 1 in 8 United States women which is approximately 12%, will grow breast cancer over the course of her lifetime. As per the Breast cancer Organization, an estimated 252710 new cases of breast cancer in the United States is expected to be diagnosed in year 2017. Thus, rising prevalence of breast cancer across the globe will generate the need for breast imaging techniques and procedures which ultimately helps to grow the breast imaging market.

Source: OBRC analysis

The report on global breast imaging market is classified on the basis of type.

Types are classified further into:

  • Ionizing Technologies
  • Non- Ionizing Technologies



 

The revenue for the above type are specific to the global breast imaging market. However, the total revenue of this type in general has been excluded from the scope of the report.

The global Breast Imaging market has been geographically segmented into:

  • North America (US & Canada)
  • Asia Pacific (China, India, Japan, Australia, Rest of Asia Pacific)
  • Europe (UK, France, Germany, Rest of Europe)
  • Rest of the World (RoW)





 

Geographically, North America dominates the global breast imaging market in terms of revenue due to rising incidence of breast cancer, rapid growth in geriatric population, ongoing technological advancements in this region and application of new breast density notification law in the United States. These are some key factors contributed for the growth in this region. Moreover, Asia-Pacific is expected to be the fastest growing region during the forecasted period of 2016-2023. Factors that are responsible for the growth in this region are rising healthcare expenditure, rising patient population, higher government spending on breast cancer research studies and implementation of several programs regarding creating awareness about early detection of breast cancer. 

The global Breast Imaging market is segmented on the basis of type segment. However,  type segment  is classified  into ionizing technologies and non-ionizing technologies. Moreover, ioning technologies includes full-field digital mammography(FFDM), 3D breast tomosynthesis , analog mammography , computed tomography(PET-CT) , positron emission tomography, molecular breast- specific  gamma imaging (MBI/BSGI_, electric impedance tomography and cone-beam computed tomography.( CBCT). Non ioinizing technologies includes breast MRI, automated whole-breast ultrasound and optical imaging. However, 3D breast tomosysthesis segment is expected to be the fastest growing segment due rising regulatory approvals for 3D breast tomosynthesis systems and also be advantages offered by these.. On the basis of non-ionizing technologies segment, automated whole-breast ultrasound (AWBU) and optical imaging is expected to be the fastest growing segment due to high resolution power with 3D capacity and faster imaging .

Some of the leading market players within Global Breast Imaging market are:

  • GE Healthcare (United Kingdom)
  • Siemens Healthcare (Germany)
  • Hologic, inc (United States)
  • Philips Healthcare (Netherlands)
  • Toshiba Corporation (Japan)
  • Others







Merger & acquisition, partnership, collaboration and product launch are some of the strategies used by companies within global breast imaging market. Of these, collaboration, and merger & acquisition are primary strategies adopted by companies for increasing their market share.

For example: On March, 2016, GE Healthcare launched VIENNA , a new digital mammography system to detect breast cancer. Which is designed to improve radiology outcomes .

Company profiling showcased within global breast imaging market offers detailed analysis on company’s product portfolio, strategic initiatives, competitive landscape, market share and SCOT analysis.

Key Reason to buy the report:

  • The report include market estimation forecast and analysis for the year 2016-2023
  • The report points out scenarios that can drive, challenge, and restraint Global Breast Imaging market.
  • Company profiling within the report offers strategic initiatives, and market share analysis of major players within the market.
  • The report offers snapshot on recent regulatory and government policies impacting market growth for the forecasted period





How we are different from others:

At OBRC, our reports offer an extensive portfolio through completed market analysis along with market share, market size, and market segmentation. The DROC’s for the markets are well thought out and researched after consulting with industry experts. Global Breast imaging market showcases market analysis through models like investment vs. adoption, see saw analysis, and so on. The report also provides overview on product application, adoption and decision support within each segment. The company profiling for each major players within the market is showcased via SCOT analysis.

Key findings of the Global Breast Imaging market:

  • Rising prevalence of breast cancer and rising technological advancements in breast imaging modalities are fuelling growth in global breast imaging market.
  • North America is anticipated to hold the highest revenue share in 2016.
  • Asia-Pacific is anticipated to be a fastest growing region due to rising healthcare expenditure and higher government spending on breast cancer research studies.
  • Increasing government support.
  • Product Launch is the key strategy adopted by various market players of global breast imaging market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL BREAST CANCER IMAGING MARKET : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. PATENT ANALYSIS
2.6.6. PIPELINE ANALYSIS
2.6.7. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISING PREVALENCE OF BREAST CANCER 
3.1.2. INCREASING AWARENESS ABOUT EARLY DETECTION OF BREAST CANCER 
3.1.3. GOVERNMENT INVESTMENTS AND FUNDING FOR BREAST CANCER TREATMENT AND RELATED RESEARCH
3.1.4. RAPIDLY INCREASING AGING POPULATION 
3.1.5. LAUNCH OF ADVANCED SYSTEMS CAPABLE OF DETECTING CANCER IN WOMEN WITH DENSE BREAST TISSUE
3.1.6. TECHNOLOGICAL ADVANCEMENTS IN BREAST CANCER IMAGING MODALITIES
3.2. MARKET RESTRAINTS
3.2.1. SIDE EFFECTS OF RADIATION EXPOSURE 
3.2.2. HIGH INSTALLATION COSTS OF BREAST CANCER IMAGING SYSTEMS 
3.2.3. ERRORS IN BREAST CANCER SCREENING AND DIAGNOSIS 
3.2.4. UNFAVORABLE REIMBURSEMENT SCENARIO IN DEVELOPING COUNTRIES 
3.3. MARKET OPPORTUNITIES
3.3.1. TECHNOLOGICAL INNOVATIONS IN BREAST CANCER DETECTION 
3.3.2. EMERGING ECONOMIES OFFER HIGH GROWTH POTENTIAL 
3.4.   MARKET CHALLENGES 
3.4.1. STRINGENT REGULATORY APPROVAL PROCEDURES 
 
4. MARKET SEGMENTATION 
4.1. GLOBAL BREAST CANCER IMAGING MARKET  BY TYPE 
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL IONIZING TECHNOLOGIES  MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.1.5. SUB SEGMENTS
4.1.5.1.5.1. 3D BREAST TOMOSYNTHESIS
4.1.5.1.5.2. ANALOG MAMMOGRAPHY
4.1.5.1.5.3. CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
4.1.5.1.5.4. ELECTRIC IMPEDANCE TOMOGRAPHY
4.1.5.1.5.5. FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM)
4.1.5.1.5.6. MOLECULAR BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
4.1.5.1.5.7. POSITRON EMISSION MAMMOGRAPHY (PEM)
4.1.5.1.5.8. POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
4.1.5.2. GLOBAL NON-IONIZING TECHNOLOGIES  MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.2.5. SUB SEGMENTS
4.1.5.2.5.1. AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
4.1.5.2.5.2. BREAST MRI
4.1.5.2.5.3. BREAST THERMOGRAPHY
4.1.5.2.5.4. BREAST ULTRASOUND
4.1.5.2.5.5. OPTICAL IMAGING
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL BREAST CANCER IMAGING MARKET  BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. HOLOGIC , INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. GE HEALTHCARE 
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. SIEMENS HEALTHCARE 
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. PHILIPS HEALTHCARE 
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. FUJIFLIM HEALTHCARE 
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.5.5. STRATEGIC ANALYSIS
7.6. TOSHIBA CORPORATION 
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. GAMMA MEDICA , INC 
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. AURORA IMAGING TECHNOLOGY, INC.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. SONOCINE , INC.
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. DILON TECHNOLOGIES, INC.
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. SHIMADZU CORPORATION
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. CARESTREAM HEALTH
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. HITACHI MEDICAL CORPORATION
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. MEDTRONICS
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. COOK MEDICAL
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL BREAST CANCER IMAGING MARKET  BY  TYPE  2014-2023 ($ MILLION)
2. GLOBAL IONIZING TECHNOLOGIES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL NON-IONIZING TECHNOLOGIES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. NORTH AMERICA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
5. EUROPE BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
6. ASIA PACIFIC BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
7. REST OF THE WORLD BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL IONIZING TECHNOLOGIES  MARKET 2014-2023 ($ MILLION)
2. GLOBAL NON-IONIZING TECHNOLOGIES MARKET 2014-2023 ($ MILLION)
3. UNITED STATES (U.S.) BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
4. CANADA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
5. UNITED KINGDOM (UK) BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
6. FRANCE BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
7. GERMANY BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
8. RUSSIA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
9. ROE BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
10. INDIA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
11. CHINA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
12. JAPAN BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
13. AUSTRALIA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
14. ROAPAC BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
15. LATIN BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)
16. MENA BREAST CANCER IMAGING MARKET 2014-2023 ($ MILLION)

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion